000 01258 a2200337 4500
005 20250513085422.0
264 0 _c19960328
008 199603s 0 0 eng d
022 _a0160-9289
024 7 _a10.1002/clc.4960181106
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShipley, J B
245 0 0 _aInotropic therapy for the failing myocardium.
_h[electronic resource]
260 _bClinical cardiology
_cNov 1995
300 _a615-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAdrenergic beta-Agonists
_xtherapeutic use
650 0 4 _aCardiac Output
650 0 4 _aCardiotonic Agents
_xtherapeutic use
650 0 4 _aDigitalis Glycosides
_xtherapeutic use
650 0 4 _aDobutamine
_xtherapeutic use
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMyocardial Contraction
650 0 4 _aPhosphodiesterase Inhibitors
_xtherapeutic use
650 0 4 _aVasodilator Agents
_xtherapeutic use
650 0 4 _aVentricular Dysfunction, Left
_xphysiopathology
700 1 _aHess, M L
773 0 _tClinical cardiology
_gvol. 18
_gno. 11
_gp. 615-9
856 4 0 _uhttps://doi.org/10.1002/clc.4960181106
_zAvailable from publisher's website
999 _c8589578
_d8589578